HealthStream - HSTM Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthStream in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HSTM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSTM, but not buy additional shares or sell existing shares.
View HSTM analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12 month price objectives for HealthStream's stock. Their HSTM share price forecasts range from $23.00 to $26.00. On average, they expect the company's stock price to reach $24.50 in the next twelve months. This suggests that the stock has a possible downside of 8.7%.
View analysts price targets for HSTM or view top-rated stocks among Wall Street analysts.

HealthStream's stock was trading at $24.84 at the beginning of the year. Since then, HSTM shares have increased by 8.0% and is now trading at $26.83.
View the best growth stocks for 2023 here.

HealthStream saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 251,700 shares, a decline of 53.3% from the February 28th total of 539,300 shares. Based on an average daily volume of 118,400 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.0% of the shares of the stock are sold short.
View HealthStream's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 24th 2023.
View our HSTM earnings forecast.

HealthStream, Inc. (NASDAQ:HSTM) posted its quarterly earnings data on Monday, February, 20th. The technology company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.02. The technology company had revenue of $68.54 million for the quarter, compared to the consensus estimate of $68.18 million. HealthStream had a trailing twelve-month return on equity of 3.04% and a net margin of 4.53%. During the same quarter in the previous year, the company posted $0.05 EPS.

HealthStream declared a quarterly dividend on Monday, February 20th. Shareholders of record on Monday, April 17th will be given a dividend of $0.025 per share on Friday, April 28th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date of this dividend is Friday, April 14th.
Read our dividend analysis for HSTM.

ETFs with the largest weight of HealthStream (NASDAQ:HSTM) stock in their portfolio include Global X Cloud Computing ETF (CLOU), Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Low Volatility ETF (XSLV), Vanguard U.S. Minimum Volatility ETF (VFMV), Invesco S&P SmallCap Health Care ETF (PSCH), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), SPDR SSGA US Small Cap Low Volatility Index ETF (SMLV) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).

HealthStream (NASDAQ:HSTM) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 25.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HSTM will have a dividend payout ratio of 22.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HSTM.

HealthStream issued an update on its FY 2023 earnings guidance on Monday, February, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $277.50 million-$283.50 million, compared to the consensus revenue estimate of $266.30 million.

107 employees have rated HealthStream Chief Executive Officer Robert A. Frist Jr. on Glassdoor.com. Robert A. Frist Jr. has an approval rating of 78% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthStream investors own include Gilead Sciences (GILD), Netflix (NFLX), Johnson & Johnson (JNJ), AbbVie (ABBV), Pfizer (PFE), Tesla (TSLA), Enterprise Products Partners (EPD), Amgen (AMGN), Activision Blizzard (ATVI) and Boeing (BA).

HealthStream trades on the NASDAQ under the ticker symbol "HSTM."

HealthStream's stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (1.85%), Stephens Investment Management Group LLC (1.55%), Geode Capital Management LLC (1.54%), Heartland Advisors Inc. (1.47%), Brown Brothers Harriman & Co. (1.35%) and Granite Investment Partners LLC (1.09%). Insiders that own company stock include Frank Gordon, Jeffrey L Mclaren, Robert A Frist Jr and Tate Deborah Taylor.
View institutional ownership trends.

Shares of HSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSTM stock can currently be purchased for approximately $26.83.

HealthStream (NASDAQ:HSTM) has a market capitalization of $820.52 million and generates $266.83 million in revenue each year. The technology company earns $12.09 million in net income (profit) each year or $0.39 on an earnings per share basis.

The company employs 1,154 workers across the globe.

HealthStream's mailing address is 500 11TH AVENUE NORTH SUITE 1000, NASHVILLE TN, 37203. The official website for the company is www.healthstream.com. The technology company can be reached via phone at (615) 301-3100, via email at mollie.condra@healthstream.com, or via fax at 615-301-3200.